AbCellera Biologics Inc.
ABCL
$2.36
-$0.035-1.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 625.61M | 643.14M | 670.36M | 698.02M | 760.59M |
| Total Receivables | 92.13M | 63.24M | 67.70M | 68.78M | 64.38M |
| Inventory | -- | -- | -- | 738.00K | -- |
| Prepaid Expenses | 8.63M | 11.51M | 8.50M | 21.41M | 22.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 751.37M | 742.88M | 771.55M | 813.95M | 871.99M |
|
|
|||||
| Total Current Assets | 751.37M | 742.88M | 771.55M | 813.95M | 871.99M |
| Net Property, Plant & Equipment | 340.43M | 331.26M | 318.88M | 306.08M | 287.70M |
| Long-term Investments | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Total Other Intangibles | 42.11M | 52.58M | 85.66M | 118.74M | 120.43M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.54M | 134.22M | 80.21M | 104.93M | 94.24M |
| Total Assets | 1.36B | 1.39B | 1.41B | 1.46B | 1.49B |
|
|
|||||
| Total Accounts Payable | 34.35M | 34.80M | 26.59M | 26.91M | 28.60M |
| Total Accrued Expenses | 8.38M | 5.99M | 4.36M | 2.85M | 7.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.62M | 5.13M | 5.60M | 5.53M | 6.16M |
| Total Finance Division Other Current Liabilities | 29.27M | 33.66M | 33.84M | 69.60M | 76.55M |
| Total Other Current Liabilities | 29.27M | 33.66M | 33.84M | 69.60M | 76.55M |
| Total Current Liabilities | 76.61M | 79.57M | 70.38M | 104.88M | 119.01M |
|
|
|||||
| Total Current Liabilities | 76.61M | 79.57M | 70.38M | 104.88M | 119.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 60.74M | 66.27M | 66.45M | 68.08M | 71.22M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 167.11M | 168.89M | 164.68M | 160.22M | 145.54M |
| Total Liabilities | 304.47M | 314.73M | 301.51M | 333.18M | 335.78M |
|
|
|||||
| Common Stock & APIC | 943.53M | 928.19M | 910.79M | 892.55M | 874.25M |
| Retained Earnings | 116.93M | 151.14M | 202.25M | 239.18M | 279.79M |
| Treasury Stock & Other | -4.38M | -1.23M | -2.07M | -1.82M | -1.72M |
| Total Common Equity | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.06B | 1.08B | 1.11B | 1.13B | 1.15B |
|
|
|||||
